Latest Us Expansion News

Cobram Estate Olives Limited (ASX – CBO) delivered a record FY2025 with a 167.8% surge in net profit and doubled US branded sales, underpinning its growth strategy and sustainability commitments.

Guzman y Gomez (GYG) has reported record FY25 results, surpassing $1.18 billion in global network sales and delivering a 45.5% increase in EBITDA. The company also declared its maiden fully-franked dividend, signaling confidence in sustained growth.

Zip Co Limited’s FY25 results reveal a powerful US market expansion driving a 147% rise in cash earnings and a strategic Nasdaq dual listing consideration.

Guzman y Gomez Limited (GYG) reported a strong FY25 turnaround with revenue up 27% and a maiden fully franked dividend declared, underpinned by robust Australia segment growth and ongoing US expansion.

Zip Co has delivered a standout FY25 with cash earnings soaring 147%, driven by rapid US market expansion. The company is now considering a Nasdaq dual listing to fuel further growth.

Ovanti Limited has secured a strategic three-year partnership with Shift4 Payments to launch its innovative Buy Now Pay Later services across over 100,000 US merchants, leveraging AI-driven credit models and stablecoin-backed funding.

Smart Parking Limited delivered record FY25 results, driven by strong organic growth and the strategic acquisition of Peak Parking in the USA, setting the stage for ambitious global expansion.

Energy One Limited reported a robust 17% revenue increase and a 309% jump in net profit for FY25, declaring its first dividend since FY23 and signaling ambitions to expand into the US market through acquisitions.

Smart Parking Limited reported a transformational FY25, driven by a landmark US acquisition and strong international growth, boosting revenue by 41% and profit by 47%.

ARB Corporation Limited reported a 5.3% increase in sales revenue to $729.9 million for FY2025, driven by strong export growth and steady domestic sales, while profit after tax declined 5%. The company declared a special fully franked dividend amid ongoing US expansion efforts.

ReNerve Limited has achieved a key milestone with its first sale and clinical use of a deep dermal tissue product in the US, broadening its surgical applications beyond nerve repair. This move complements its existing nerve repair portfolio and sets the stage for further product launches later this year.

Tetratherix has landed a $3.3 million Australian Government grant to co-fund a $7.4 million project expanding its synthetic polymer production and supporting its US market entry in 2026.